Benzinga | Jul 29, 2020 09:56AM EDT

Raymond James Maintains Outperform on NeoGenomics, Raises Price Target to $40

Raymond James maintains NeoGenomics (NASDAQ:NEO) with a Outperform and raises the price target from $32 to $40.